Caxton Associates LP Lantheus Holdings, Inc. Transaction History

Caxton Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $33,293 - $40,258	404 Added 12.15%	3,729 $312,000
Q1 2023 May 15, 2023	BUY	$47.76 - $82.86 $158,802 - $275,509	3,325 New	3,325 $274,000
Q3 2019 Nov 14, 2019	SELL	$21.01 - $28.94 $213,818 - $294,522	-10,177 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$23.33 - $28.3 $35,018 - $42,478	-1,501 Reduced 12.85%	10,177 $288,000
Q1 2019 May 15, 2019	BUY	$14.93 - $25.1 $174,352 - $293,117	11,678 New	11,678 $286,000

539

69.9M

651K

459K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.63B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.